Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting the Hepatic BMP-SMAD Pathway in Leptin Receptor Deficiency (LEPRD): A New Strategy for Treating Severe Genetic Obesity or Leptin Deficiency

NCT07833592 is registered in ClinicalTrials.gov with Azienda Ospedaliero Universitaria Maggiore della Carita as lead sponsor.

NCT NCT07833592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07833592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting the Hepatic BMP-SMAD Pathway in Leptin Receptor Deficiency (LEPRD): A New Strategy for Treating Severe Genetic Obesity or Leptin Deficiency
Lead sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita
Phase
Observational
Overall status
Recruiting
Start date
September 10, 2026
Completion date
September 30, 2029
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leptin receptor deficiency obesity